Bioptik Technology Incorporation (TPEX:4161)
Taiwan · Delayed Price · Currency is TWD 22.85
-0.05 (-0.22%)
May 29, 2026, 1:30 PM CST
TPEX:4161 Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 73.94 | 71.19 | 93.57 | 85.71 | 48.5 | 22.59 |
Depreciation & Amortization | 32.59 | 32.77 | 35.64 | 34.72 | 33.47 | 36.98 |
Loss (Gain) From Sale of Assets | -1.45 | -1.22 | 0.9 | -0.02 | -0.06 | -0 |
Loss (Gain) From Sale of Investments | -20.72 | -17.25 | -4.63 | -8.69 | 6.14 | 5.72 |
Stock-Based Compensation | 7.31 | 8.15 | 8.75 | 5.41 | - | - |
Provision & Write-off of Bad Debts | -0.08 | -0.2 | 0.15 | 0.29 | -0.22 | -0.29 |
Other Operating Activities | -11.16 | -11.82 | -0.09 | 5.59 | 12.86 | -2.95 |
Change in Accounts Receivable | -3.64 | 4.87 | 23.7 | -15.25 | 5.18 | -10.64 |
Change in Inventory | -11.88 | 2.22 | 29.62 | 71.09 | -92.75 | -39.29 |
Change in Accounts Payable | 23 | 9.47 | -28.71 | 12.81 | -31.96 | 34.75 |
Change in Other Net Operating Assets | -82.12 | -48 | 11.41 | 9.03 | 73.9 | -92.09 |
Operating Cash Flow | 8.21 | 59.99 | 158.82 | 205.95 | 55.06 | -41.15 |
Operating Cash Flow Growth | -93.83% | -62.23% | -22.88% | 274.07% | - | - |
Capital Expenditures | -19.73 | -19.17 | -14.93 | -30.42 | -16.93 | -19.14 |
Sale of Property, Plant & Equipment | 2.14 | 1.91 | 0.07 | 0.38 | 0.06 | 0.01 |
Sale (Purchase) of Intangibles | -1.68 | -3.63 | -0.58 | -0.62 | -0.15 | -0.69 |
Investment in Securities | -16.42 | -16.42 | 2.35 | 2.53 | 204.16 | -98.8 |
Other Investing Activities | 1.17 | 0.04 | 0.66 | -0.41 | -0 | - |
Investing Cash Flow | -34.52 | -37.28 | -12.44 | -28.53 | 187.14 | -118.61 |
Short-Term Debt Issued | - | 645 | 690 | 1,082 | 990 | 610 |
Total Debt Issued | 650 | 645 | 690 | 1,082 | 990 | 610 |
Short-Term Debt Repaid | - | -610 | -760 | -1,182 | -970 | -550 |
Long-Term Debt Repaid | - | -26.26 | -26.2 | -44.08 | -41.12 | -41.25 |
Total Debt Repaid | -636.2 | -636.26 | -786.2 | -1,226 | -1,011 | -591.25 |
Net Debt Issued (Repaid) | 13.81 | 8.74 | -96.2 | -144.08 | -21.12 | 18.76 |
Issuance of Common Stock | - | - | - | 24 | - | - |
Repurchase of Common Stock | -0.18 | -0.18 | -1.07 | - | - | - |
Common Dividends Paid | -15.88 | -15.88 | -37.09 | - | -14.48 | -14.48 |
Other Financing Activities | 3.25 | 3.25 | - | 0.75 | 0.04 | 1.38 |
Financing Cash Flow | 0.99 | -4.07 | -134.36 | -119.33 | -35.56 | 5.65 |
Foreign Exchange Rate Adjustments | -0.01 | -0 | 0.02 | -0.01 | 0.01 | -0.01 |
Net Cash Flow | -25.33 | 18.64 | 12.05 | 58.08 | 206.65 | -154.12 |
Free Cash Flow | -11.52 | 40.82 | 143.9 | 175.53 | 38.13 | -60.29 |
Free Cash Flow Growth | - | -71.63% | -18.02% | 360.35% | - | - |
Free Cash Flow Margin | -1.33% | 4.88% | 16.63% | 21.19% | 4.97% | -8.17% |
Free Cash Flow Per Share | -0.19 | 0.69 | 2.45 | 3.03 | 0.66 | -1.05 |
Cash Interest Paid | 7.81 | 7.61 | 9.13 | 11 | 9.19 | 7.82 |
Cash Income Tax Paid | 26.13 | 26.17 | 17.72 | 14.97 | 0.43 | 0.1 |
Levered Free Cash Flow | -10.04 | 13.23 | 115.68 | 133.43 | 2.52 | -72.18 |
Unlevered Free Cash Flow | -5.16 | 17.99 | 121.38 | 140.3 | 8.26 | -67.29 |
Change in Working Capital | -72.23 | -21.64 | 24.53 | 82.94 | -45.64 | -103.21 |